|
|||||
|
|
Ibandronate and Ventricular Arrhythmia Risk |
|
| Authors: | INGRID M. BONILLA PEDRO VARGAS‐PINTO D.V.M. Ph.D. YOSHINORI NISHIJIMA D.V.M. Ph.D. ADRIANA PEDRAZA‐TOSCANO D.V.M. Ph.D. HSIANG‐TING HO Ph.D. VICTOR P. LONG III Pharm.D. ANDRIY E. BELEVYCH Ph.D. PATRIC GLYNN MAHMOUD HOUMSSE M.D. TROY RHODES M.D. RAUL WEISS M.D. THOMAS J. HUND Ph.D. ROBERT L. HAMLIN D.V.M. Ph.D. SANDOR GYÖRKE Ph.D. CYNTHIA A. CARNES Pharm.D. Ph.D. |
| Affiliation: | 1. College of Pharmacy;2. College of Veterinary Medicine;3. College of Medicine;4. Dorothy M. Davis Heart and Lung Research Institute, the Ohio State University, , Columbus, Ohio, USA;5. QTest Labs, , Columbus, Ohio, USA |
| Abstract: | |
| Keywords: | biophosphonates calcium ibandronate ion channels long‐QT pharmacology potassium proarrhythmia Torsade de Pointes |